BTTX - Better Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

BTTX is currently covered by 2 analysts with an average price target of $6.31. This is a potential upside of $6.3 (63000%) from yesterday's end of day stock price of $0.01.

Better Therapeutics's activity chart (see below) currently has 2 price targets and 9 ratings on display. The stock rating distribution of BTTX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for BTTX is $3, Lowest price target is $3, average price target is $6.31.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 10-Aug-2023. First documented stock forecast 24-Nov-2021.

Best performing analysts who are covering BTTX - Better Therapeutics:

Keay Nakae Thomas Flaten

Currently out of the existing stock ratings of BTTX, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7 months 18 days ago

0/2 (0%)

$10.32 (154.49%)

Buy

3

$2.85 (1900.00%)

5

7 months 18 days ago

0/2 (0%)

$2.27 (310.96%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTTX (Better Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on BTTX (Better Therapeutics) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on BTTX (Better Therapeutics) with a proven track record?

THOMAS FLATEN

Which analyst has the most public recommendations on BTTX (Better Therapeutics)?

Keay Nakae works at CHARDAN CAPITAL and has 7 price targets and 5 ratings on BTTX

Which analyst is the currently most bullish on BTTX (Better Therapeutics)?

Thomas Flaten with highest potential upside - $2.85

Which analyst is the currently most reserved on BTTX (Better Therapeutics)?

Keay Nakae with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?